Larry Sullivan

InvestorPlace contributor

Recent Articles

Dip Your Toes in iBio Stock, but Remember That Viability Is Still an Issue

By Larry Sullivan, InvestorPlace contributor

There's promise in IBIO stock but potential investors need to study the biotech company carefully before placing their bets.

Further Cruise Cancellations Make Case to Steer Clear of Carnival Stock

By Larry Sullivan, InvestorPlace contributor

Covid-19 is crushing the travel industry, especially cruise operators. Now is not the time to buy shares of CCL stock.

Load More